SMTL ID : 2w7x.1

Cellular inhibition of checkpoint kinase 2 and potentiation of cytotoxic drugs by novel Chk2 inhibitor PV1019

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.07 Å

Oligo State

homo-dimer

Ligands

2 x D1A: N-[4-[(E)-N-carbamimidamido-C-methyl-carbonimidoyl]phenyl]-7-nitro-1H-indole-2-carboxamide(Non-covalent)

D1A.1: 15 residues within 4Å: Chain A: L.18, V.26, A.39, K.41, I.43, E.65, L.93, L.95, M.96, E.97, G.99, L.146, T.159, D.160, G.162 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:L.18, A:V.26, A:K.41, A:K.41, A:L.93, A:T.159 Hydrogen bonds: A:G.162 Water bridges: A:K.41, A:K.41, A:M.96, A:D.160, A:D.160, A:D.160, A:G.162 Salt bridges: A:E.65, A:D.160 D1A.6: 15 residues within 4Å: Chain B: L.18, V.26, A.39, K.41, I.43, E.65, L.93, L.95, M.96, E.97, G.99, L.146, T.159, D.160, G.162 17 PLIP interactions: 17 interactions with chain B Hydrophobic interactions: B:L.18, B:V.26, B:K.41, B:K.41, B:L.93, B:T.159 Hydrogen bonds: B:G.162 Water bridges: B:K.41, B:K.41, B:E.65, B:M.96, B:D.160, B:D.160, B:D.160, B:G.162 Salt bridges: B:E.65, B:D.160

2 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 3 residues within 4Å: Chain A: D.139, D.160, H.163 5 PLIP interactions: 2 interactions with chain A, 3 Ligand-Water interactions Metal complexes: A:D.139, A:D.160, H2O.4, H2O.4, H2O.4 MG.7: 3 residues within 4Å: Chain B: D.139, D.160, H.163 5 PLIP interactions: 2 interactions with chain B, 3 Ligand-Water interactions Metal complexes: B:D.139, B:D.160, H2O.11, H2O.12, H2O.12

2 x NO3: NITRATE ION(Non-functional Binders)

NO3.3: 5 residues within 4Å: Chain A: L.167, G.195, Y.196, N.197, R.198 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:N.197, A:N.197, A:R.198, A:R.198, A:R.198 NO3.8: 5 residues within 4Å: Chain B: L.167, G.195, Y.196, N.197, R.198 5 PLIP interactions: 5 interactions with chain B Hydrogen bonds: B:N.197, B:N.197, B:R.198, B:R.198, B:R.198

4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.4: 5 residues within 4Å: Chain A: D.253, K.257, F.267, H.275, P.276 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:D.253, A:K.257 EDO.5: 4 residues within 4Å: Chain A: K.229 Chain B: L.188, V.189, G.192 3 PLIP interactions: 2 interactions with chain B, 1 interactions with chain A Hydrogen bonds: B:L.188, B:G.192 Water bridges: A:K.229 EDO.9: 5 residues within 4Å: Chain B: D.253, K.257, F.267, H.275, P.276 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:D.253, B:K.257 EDO.10: 4 residues within 4Å: Chain A: L.188, V.189, G.192 Chain B: K.229 3 PLIP interactions: 1 interactions with chain B, 2 interactions with chain A Water bridges: B:K.229 Hydrogen bonds: A:L.188, A:G.192

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Jobson, A.G. et al., Cellular Inhibition of Chk2 Kinase and Potentiation of Camptothecins and Radiation by the Novel Chk2 Inhibitor Pv1019. J.Pharmacol.Exp.Ther. (2009)

Release Date

2009-09-22

Peptides

SERINE/THREONINE-PROTEIN KINASE CHK2: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

SERINE/THREONINE-PROTEIN KINASE CHK2

Related Entries With Identical Sequence